Bayer records mixed results for key OTC brands

29 July 2016 - Deborah Wilkes

Archived

Bayer's Consumer Health division reported worldwide sales up by 4.0% on a currency- and portfolio-adjusted basis in the second quarter of 2016. The German company said Aspirin, Bepanthen/Bepanthol, Canesten and Claritin had all "posted very high growth rates", but other key brands fared less well.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: